Literature DB >> 6195745

Methods to detect and quantitate complement activation.

N R Cooper, G R Nemerow, J T Mayes.   

Abstract

Mesh：

Substances：

Year:  1983        PMID： 6195745     DOI： 10.1007/bf00205873

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  45 in total

1.  Active disassembly of the first complement component, C-1, by C-1 inactivator.

Authors:  R J Ziccardi; N R Cooper
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

2.  Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.

Authors:  L H Perrin; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

Review 3.  The biology and detection of immune complexes.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

4.  Quantitation of Clr-Cls-Cl inactivator complexes by electroimmunoassay.

Authors:  A B Laurell; U Mårtensson; A G Sjöholm
Journal:  Acta Pathol Microbiol Scand C       Date:  1979-02

5.  Detection and partial characterization of circulating immune complexes with solid-phase anti-C3.

Authors:  A B Pereira; A N Theofilopoulos; F J Dixon
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

6.  Quantitation of human complement fragment C4ai in physiological fluids by competitive inhibition radioimmune assay.

Authors:  J P Gorski
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

7.  Modulation of the antigenicity of C1r and C1s by C1 inactivator.

Authors:  R J Ziccardi; N R Cooper
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

8.  Breakdown products of C 3 in human synovial fluids.

Authors:  N J Zvaifler
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

9.  Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.

Authors:  J T Mayes; R D Schreiber; N R Cooper
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

10.  The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor.

Authors:  O D Ratnoff; J Pensky; D Ogston; G B Naff
Journal:  J Exp Med       Date:  1969-02-01       Impact factor: 14.307
View more
  17 in total

1.  Effects of block copolymer properties on nanocarrier protection from in vivo clearance.

Authors:  Suzanne M D'Addio; Walid Saad; Steven M Ansell; John J Squiers; Douglas H Adamson; Margarita Herrera-Alonso; Adam R Wohl; Thomas R Hoye; Christopher W Macosko; Lawrence D Mayer; Christine Vauthier; Robert K Prud'homme
Journal:  J Control Release       Date:  2012-06-23       Impact factor: 9.776

Review 2.  Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal?

Authors:  M Peakman; G Senaldi; D Vergani
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

3.  Designed IgM from glycoengineering.

Authors:  Andrew Hiatt
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-15       Impact factor: 11.205

4.  Complement C4 monitoring in the follow-up of chronic hepatitis C treatment.

Authors:  C Dumestre-Perard; D Ponard; C Drouet; V Leroy; J-P Zarski; N Dutertre; M G Colomb
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

5.  Terminal complement complexes and C1/C1 inhibitor complexes in autoimmune thyroid disease.

Authors:  A P Weetman; S B Cohen; D A Oleesky; B P Morgan
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

6.  Complement in type 1 (insulin-dependent) diabetes.

Authors:  G Senaldi; B A Millward; M J Hussein; D Pyke; R D Leslie; D Vergani
Journal:  Diabetologia       Date:  1987-10       Impact factor: 10.122

7.  A peptide extension dictates IgM assembly.

Authors:  Dzana Pasalic; Benedikt Weber; Chiara Giannone; Tiziana Anelli; Roger Müller; Claudio Fagioli; Manuel Felkl; Christine John; Maria Francesca Mossuto; Christian F W Becker; Roberto Sitia; Johannes Buchner
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-27       Impact factor: 11.205

Review 8.  Apoptotic cell responses in the splenic marginal zone: a paradigm for immunologic reactions to apoptotic antigens with implications for autoimmunity.

Authors:  Tracy L McGaha; Mikael C I Karlsson
Journal:  Immunol Rev       Date:  2016-01       Impact factor: 12.988

9.  Complement activation in patients with renal failure as detected through the quantitation of fragments of the complement proteins C3, C5, and factor B.

Authors:  M Oppermann; M Haubitz; E Quentin; O Götze
Journal:  Klin Wochenschr       Date:  1988-09-15

Review 10.  IgM in microbial infections: taken for granted?

Authors:  Rachael Racine; Gary M Winslow
Journal:  Immunol Lett       Date:  2009-06-17       Impact factor: 3.685
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.